The mammary progenitor marker CD61/β3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis

François Vaillant, Marie-Liesse Labat, Mark Shackleton, Natasha C. Forrest, Geoffrey J. Lindeman, Jane E. Visvader

Research output: Contribution to journalArticle

228 Citations (Scopus)

Abstract

The cells of origin and mechanisms that underpin tumor heterogeneity in breast cancer are poorly understood. Here, we have examined three mouse models of mammary tumorigenesis (MMTV-wnt-1, MMTV-neu, and p53+/-) for changes in their epithelial cell hierarchy during the preneoplastic and neoplastic stages of tumor progression. In preneoplastic tissue, only MMTV-wnt-1 mice showed a perturbation in their epithelial subpopulations. In addition to an expanded mammary stem cell pool, repopulating cells capable of yielding extensive mammary outgrowths in vivo were revealed in the committed luminal progenitor population. These findings indicate that wnt-1 activation induces the appearance of aberrant progenitor cells, and suggest that both mammary stem and progenitor cells can serve as the cellular targets of wnt-1-induced tumorigenesis. In tumors arising in MMTV-wnt-1 tumors, the luminal epithelial progenitor marker CD61/β3 integrin identified a cancer stem cell (CSC) population that was highly enriched for tumorigenic capability relative to the CD61- subset. CD61 expression also defined a CSC subset in 50% of p53+/--derived tumors. No CSCs, however, could be identified in the more homogeneous MMTV-neu/erbB2 model, suggesting an alternative model of tumorigenesis. Overall, our findings show the utility of the progenitor marker CD61 in the identification of CSCs that sustain specific mammary tumors.

Original languageEnglish (US)
Pages (from-to)7711-7717
Number of pages7
JournalCancer Research
Volume68
Issue number19
DOIs
StatePublished - Oct 1 2008
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Integrins
Carcinogenesis
Breast
Stem Cells
Neoplasms
Breast Neoplasms
Population
Epithelial Cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The mammary progenitor marker CD61/β3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. / Vaillant, François; Labat, Marie-Liesse; Shackleton, Mark; Forrest, Natasha C.; Lindeman, Geoffrey J.; Visvader, Jane E.

In: Cancer Research, Vol. 68, No. 19, 01.10.2008, p. 7711-7717.

Research output: Contribution to journalArticle

Vaillant, François ; Labat, Marie-Liesse ; Shackleton, Mark ; Forrest, Natasha C. ; Lindeman, Geoffrey J. ; Visvader, Jane E. / The mammary progenitor marker CD61/β3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. In: Cancer Research. 2008 ; Vol. 68, No. 19. pp. 7711-7717.
@article{c9dc664b367e421cba642ddc57078c75,
title = "The mammary progenitor marker CD61/β3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis",
abstract = "The cells of origin and mechanisms that underpin tumor heterogeneity in breast cancer are poorly understood. Here, we have examined three mouse models of mammary tumorigenesis (MMTV-wnt-1, MMTV-neu, and p53+/-) for changes in their epithelial cell hierarchy during the preneoplastic and neoplastic stages of tumor progression. In preneoplastic tissue, only MMTV-wnt-1 mice showed a perturbation in their epithelial subpopulations. In addition to an expanded mammary stem cell pool, repopulating cells capable of yielding extensive mammary outgrowths in vivo were revealed in the committed luminal progenitor population. These findings indicate that wnt-1 activation induces the appearance of aberrant progenitor cells, and suggest that both mammary stem and progenitor cells can serve as the cellular targets of wnt-1-induced tumorigenesis. In tumors arising in MMTV-wnt-1 tumors, the luminal epithelial progenitor marker CD61/β3 integrin identified a cancer stem cell (CSC) population that was highly enriched for tumorigenic capability relative to the CD61- subset. CD61 expression also defined a CSC subset in 50{\%} of p53+/--derived tumors. No CSCs, however, could be identified in the more homogeneous MMTV-neu/erbB2 model, suggesting an alternative model of tumorigenesis. Overall, our findings show the utility of the progenitor marker CD61 in the identification of CSCs that sustain specific mammary tumors.",
author = "Fran{\cc}ois Vaillant and Marie-Liesse Labat and Mark Shackleton and Forrest, {Natasha C.} and Lindeman, {Geoffrey J.} and Visvader, {Jane E.}",
year = "2008",
month = "10",
day = "1",
doi = "10.1158/0008-5472.CAN-08-1949",
language = "English (US)",
volume = "68",
pages = "7711--7717",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - The mammary progenitor marker CD61/β3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis

AU - Vaillant, François

AU - Labat, Marie-Liesse

AU - Shackleton, Mark

AU - Forrest, Natasha C.

AU - Lindeman, Geoffrey J.

AU - Visvader, Jane E.

PY - 2008/10/1

Y1 - 2008/10/1

N2 - The cells of origin and mechanisms that underpin tumor heterogeneity in breast cancer are poorly understood. Here, we have examined three mouse models of mammary tumorigenesis (MMTV-wnt-1, MMTV-neu, and p53+/-) for changes in their epithelial cell hierarchy during the preneoplastic and neoplastic stages of tumor progression. In preneoplastic tissue, only MMTV-wnt-1 mice showed a perturbation in their epithelial subpopulations. In addition to an expanded mammary stem cell pool, repopulating cells capable of yielding extensive mammary outgrowths in vivo were revealed in the committed luminal progenitor population. These findings indicate that wnt-1 activation induces the appearance of aberrant progenitor cells, and suggest that both mammary stem and progenitor cells can serve as the cellular targets of wnt-1-induced tumorigenesis. In tumors arising in MMTV-wnt-1 tumors, the luminal epithelial progenitor marker CD61/β3 integrin identified a cancer stem cell (CSC) population that was highly enriched for tumorigenic capability relative to the CD61- subset. CD61 expression also defined a CSC subset in 50% of p53+/--derived tumors. No CSCs, however, could be identified in the more homogeneous MMTV-neu/erbB2 model, suggesting an alternative model of tumorigenesis. Overall, our findings show the utility of the progenitor marker CD61 in the identification of CSCs that sustain specific mammary tumors.

AB - The cells of origin and mechanisms that underpin tumor heterogeneity in breast cancer are poorly understood. Here, we have examined three mouse models of mammary tumorigenesis (MMTV-wnt-1, MMTV-neu, and p53+/-) for changes in their epithelial cell hierarchy during the preneoplastic and neoplastic stages of tumor progression. In preneoplastic tissue, only MMTV-wnt-1 mice showed a perturbation in their epithelial subpopulations. In addition to an expanded mammary stem cell pool, repopulating cells capable of yielding extensive mammary outgrowths in vivo were revealed in the committed luminal progenitor population. These findings indicate that wnt-1 activation induces the appearance of aberrant progenitor cells, and suggest that both mammary stem and progenitor cells can serve as the cellular targets of wnt-1-induced tumorigenesis. In tumors arising in MMTV-wnt-1 tumors, the luminal epithelial progenitor marker CD61/β3 integrin identified a cancer stem cell (CSC) population that was highly enriched for tumorigenic capability relative to the CD61- subset. CD61 expression also defined a CSC subset in 50% of p53+/--derived tumors. No CSCs, however, could be identified in the more homogeneous MMTV-neu/erbB2 model, suggesting an alternative model of tumorigenesis. Overall, our findings show the utility of the progenitor marker CD61 in the identification of CSCs that sustain specific mammary tumors.

UR - http://www.scopus.com/inward/record.url?scp=54249086214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249086214&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-08-1949

DO - 10.1158/0008-5472.CAN-08-1949

M3 - Article

VL - 68

SP - 7711

EP - 7717

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 19

ER -